Effect of treatment on maximal expiratory flow rates in tropical eosinophilia
dc.contributor.author | Kuppurao, K.V. | |
dc.contributor.author | Vijayan, V.K. | |
dc.contributor.author | Venkatesan, P. | |
dc.contributor.author | Sankaran, K. | |
dc.date.accessioned | 2016-01-14T08:39:58Z | |
dc.date.available | 2016-01-14T08:39:58Z | |
dc.date.issued | 1993 | |
dc.identifier.citation | The Ceylon Medical Journal, 38(2)pp.78-80 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/20500 | |
dc.publisher | The Sri Lanka Medical Association:Colombo | |
dc.subject | Medical Sciences | |
dc.subject | Respiratory disorders | |
dc.subject | Lung diseases | |
dc.subject | Eosinophilic inflammation | |
dc.subject | Diethylcarbamazine | |
dc.subject | Drug therapy | |
dc.title | Effect of treatment on maximal expiratory flow rates in tropical eosinophilia | |
dc.type | Article |